Last reviewed · How we verify

NCT05141370

Assessment of a Femtosecond Laser to Perform Capsulorhexis During Cataract Surgery

Completed NA Last updated 2 October 2023
What this trial tests

NA trial testing cataract surgery with CATSYS in Cataract Surgery in 83 participants. Completed in 3 April 2023.

Timeline
3 February 2022
Primary endpoint
3 April 2023
3 April 2023

Quick facts

Lead sponsorIlasis Laser
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment83
Start date3 February 2022
Primary completion3 April 2023
Estimated completion3 April 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Ilasis Laser

Who can join

18 and older, any sex, with Cataract Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a Pre-market first-in-man clinical investigation to validate performance of a hand-held femtosecond laser named CATSYS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cataract Surgery

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05141370.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing